Skip to main content

Table 1 Baseline characteristics of the study population according to the type of plaques

From: Sex-related differences in the association between plasma fibrinogen and non-calcified or mixed coronary atherosclerotic plaques

Variables NP
(n = 79)
CP
(n = 120)
NCP/MP
(n = 130)
P
Age (years) 50.1 ± 9.1 61.4 ± 9.4 58.2 ± 9.7 < 0.001
BMI (kg/m2) 25.1 ± 3.3 25.6 ± 3.6 25.8 ± 3.9 0.331
Male, n (%) 39 (49.4%) 74 (61.7%) 92 (70.8%) 0.008
Hypertension, n (%) 28 (35.4%) 81 (67.5%) 84 (64.6%) < 0.001
Diabetes, n (%) 12 (15.2%) 29 (24.2%) 41 (31.5%) 0.029
Dyslipidemia, n (%) 39 (49.4%) 94 (78.3%) 114 (87.7%) < 0.001
Smoking, n (%) 16 (20.3%) 31 (25.8%) 43 (33.1%) 0.117
Alcohol consumption, n (%) 24 (30.4%) 38 (31.7%) 42 (32.3%) 0.959
History of CAD, n (%) 12 (15.2%) 15 (12.5%) 17 (13.1%) 0.855
Biochemical parameters
 TC (mmol/L) 4.95 ± 0.91 4.61 ± 1.46 4.57 ± 1.29 0.092
 TG (mmol/L) 1.50 (1.18, 2.19) 1.53 (1.03, 2.17) 1.57 (1.17, 2.25) 0.581
 HDL-C (mmol/L) 1.20 ± 0.36 1.21 ± 0.33 1.10 ± 0.28 0.019
 LDL-C (mmol/L) 3.07 ± 0.77 2.69 ± 0.88 2.78 ± 1.00 0.012
 hsCRP (mg/L) 1.20 (0.65, 2.10) 1.31 (0.64, 2.80) 1.64 (0.81, 2.96) 0.070
 FIB (g/L) 3.09 ± 0.69 3.06 ± 0.53 3.31 ± 0.79 0.010
Medications, n (%)
 Statins 30 (38.0%) 83 (69.2%) 100 (76.9%) < 0.001
 Aspirin 37 (46.8%) 95 (79.2%) 107 (82.3%) < 0.001
 Calcium antagonists 13 (16.5%) 56 (46.7%) 39 (30.0%) < 0.001
 ARB/ACEI 17 (21.5%) 49 (40.8%) 61 (46.9%) 0.001
 Beta-blockers 24 (30.4%) 62 (51.7%) 70 (53.8%) 0.002
 Diuretics 6 (7.6%) 28 (23.3%) 28 (21.5%) 0.013